As for this invention, formula (i)< Conversion 13 >(In formula, as fora R,b R,c R,d R,e R, andf R, as in definition is in the bill,) preparation manner of chemical compound and particular chemical compound, the medicine constituent which includes particular chemical compound, phosphatidyl inositol 3 kinase (PI3K) and mammalian rapamycin target protein (mTOR), signal transmission Characteristic transcription factor 3 (STAT3), tumor necrosis factor (TNF ), interleukin 6 (IL 6), or in remedying of the disease where these combinations lie between, the especially cancer and the use of the particular chemical compound in remedying of the inflammation it regards.< Choice figure >It is not本発明は、式(I)【化13】(式中、Ra、Rb、Rc、Rd、Re、およびRfは、明細書中で定義の通りである)の化合物、当該化合物の調製方法、当該化合物を含む医薬組成物、ホスファチジルイノシトール-3-キナーゼ(PI3K)、哺乳類ラパマイシン標的タンパク質(mTOR)、シグナル伝達性転写因子3(STAT3)、腫瘍壊死因子-α(TNF-α)、インターロイキン6(IL-6)、またはこれらの組み合わせが介在する疾患の治療における、特に癌および炎症の治療における当該化合物の使用に関する。【選択図】なし
